TMCnet News

Global Tissue Diagnostics Market Forecast to 2022 - Driven by Increasing Prevalence of Chronic Diseases - Research and Markets
[July 13, 2016]

Global Tissue Diagnostics Market Forecast to 2022 - Driven by Increasing Prevalence of Chronic Diseases - Research and Markets


Research and Markets has announced the addition of the "Global Tissue Diagnostics Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering.

The global tissue diagnostics market is expected to reach $4811.9 million by 2022, growing at 8.6%. In regional outlook, market is divided into North America, Europe, Asia Pacific and rest of the world. North America dominates the global tissue diagnostics market, which accounts for around 40.7% of the global market share.

The major reason boosting the North American region upward is the rising patient's awareness level, presence of technologically advanced products, and the rising healthcare expenditure. The United States and Canada are the major countries in North American region that boost the market growth. Asia Pacific is the fastest growing global tissue diagnostics market, due to rapid improvement in healthcare infrastructure, presence of sophisticated healthcare facilities in the developed markets of Australia and Japan.

Asia Pacific is one of the most profitable and revenue generating market or major market players in the forecast period. China, Japan, South Korea and Australia are the major countries in Asia Pacific region. Europe is showing positive growth due to rising prevalence of cancer in this region, favorable government policies related to tissue diagnostics and increasing geriatric population. Rest of the world is showing positive growth rate for the global tissue diagnostics market in the forecast period. Brazil and Middle East is the major countries in the Rest of the world region.



The global tissue diagnostics market is rising rapidly and is demanding for effective tissue diagnostic procedures majorly due to increasing prevalence of chronic diseases, such as liver cancer, brain cancer, lung cancer, colorectal, breast cancer, cervical cancers, cardiovascular disorders, malaria, and diabetes and many more. Apart from this, the increased use of biomarkers for disease diagnosis has a positive impact on the market for global tissue diagnostics in the forecast period.

Companies Mentioned:


  • Roche
  • Abbott Laboratories, Inc.
  • Agilent Technologies (News - Alert)
  • Biogenex Laboratories
  • Bio Sb.
  • Cell Signalling Technology, Inc.
  • Qiagen
  • Becton Dickinson & Company
  • Alere
  • Diagenic
  • Medtronic Inc
  • Stryker
  • Biomeriux
  • Prometheus Laboratories
  • Danaher Corporation (News - Alert).

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Sector Analysis

5. Market Segmentation

6. Competitive Landscape

7. Geographical Analysis

8. Company Profiles

For more information visit http://www.researchandmarkets.com/research/d36f28/global_tissue


[ Back To TMCnet.com's Homepage ]